Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001558370-25-000053
Filing Date
2025-01-07
Accepted
2025-01-07 16:35:25
Documents
17
Period of Report
2024-10-31
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A pahc-20241031x8ka.htm   iXBRL 8-K/A 41357
2 EX-23.1 pahc-20241031xex23d1.htm EX-23.1 2138
3 EX-99.1 pahc-20241031xex99d1.htm EX-99.1 298137
4 EX-99.2 pahc-20241031xex99d2.htm EX-99.2 256859
5 EX-99.3 pahc-20241031xex99d3.htm EX-99.3 592088
  Complete submission text file 0001558370-25-000053.txt   1405331

Data Files

Seq Description Document Type Size
6 EX-101.SCH pahc-20241031.xsd EX-101.SCH 3406
7 EX-101.LAB pahc-20241031_lab.xml EX-101.LAB 15898
8 EX-101.PRE pahc-20241031_pre.xml EX-101.PRE 10314
19 EXTRACTED XBRL INSTANCE DOCUMENT pahc-20241031x8ka_htm.xml XML 4979
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-36410 | Film No.: 25515298
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)